Managers / Q1 2026
Lunate Capital Ltd
CIK 0002056786 · UNIT 1, FLOOR 12, AL MARYAH TOWER, ABU DHABI GLOBAL MARKET SQUARE, AL MARYAH ISLAND, ABU DHABI, C0, 00000 · 971.2.877.8896
Summary
Lunate Capital Ltd reported $120M in U.S.-listed holdings across 6 positions for Q1 2026.
The portfolio is heavily concentrated: RVMD alone accounts for 44.4% of reported value.
The book was largely unchanged from Q4 2025.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 83.0% · $100M
- REIT · 16.3% · $20M
- Equity WRT · 0.7% · $805,500
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| RVMDREVOLUTION MEDICINES INC | TRIMMED | −1.65M | 549.0K | −$122M | $53M |
| SAILSAILPOINT INC | HELD | +0 | 3.00M | −$21M | $40M |
| LINELINEAGE INC | HELD | +0 | 600.0K | −$1M | $20M |
| NAVNNAVAN INC | HELD | +0 | 200.0K | −$768,000 | $3M |
| RVMDWREVOLUTION MEDICINES INC | HELD | +0 | 450.0K | +$382,545 | $805,500 |
| NMRANEUMORA THERAPEUTICS INC. | HELD | +0 | 2.12M | +$339,863 | $4M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | COM · *W EXP 12/17/202 | 45.03% | $54M | 999.0K |
| 2 | SAILSAILPOINT INChistory → | COM | 33.00% | $40M | 3.00M |
| 3 | LINELINEAGE INChistory → | COM | 16.33% | $20M | 600.0K |
| 4 | NMRANEUMORA THERAPEUTICS INC.history → | COM | 3.44% | $4M | 2.12M |
| 5 | NAVNNAVAN INChistory → | CL A | 2.20% | $3M | 200.0K |
Filing History
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- Lunate Holding RSC Ltd028-25201
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.